CXCL3 and breast carcinoma: CXCL3 binds to CXCR2, a receptor on breast cancer cells, and activates FAK, which promotes a mesenchymal phenotype, invasion, and metastasis of breast cancer cells (41) F12 expression might affect the OS of PTC patients by regulating metabolic pathways (42).